Compare GRDN & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRDN | ENVX |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Industrial Machinery/Components |
| Sector | Consumer Staples | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2024 | N/A |
| Metric | GRDN | ENVX |
|---|---|---|
| Price | $30.97 | $7.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $32.00 | $17.14 |
| AVG Volume (30 Days) | 293.5K | ★ 6.2M |
| Earning Date | 11-10-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $1,389,638,000.00 | $30,273,000.00 |
| Revenue This Year | $19.50 | $36.91 |
| Revenue Next Year | $0.48 | $117.80 |
| P/E Ratio | $111.10 | ★ N/A |
| Revenue Growth | 18.68 | ★ 45.98 |
| 52 Week Low | $17.78 | $5.27 |
| 52 Week High | $37.43 | $16.49 |
| Indicator | GRDN | ENVX |
|---|---|---|
| Relative Strength Index (RSI) | 55.34 | 47.03 |
| Support Level | $30.68 | $7.21 |
| Resistance Level | $31.96 | $8.89 |
| Average True Range (ATR) | 1.11 | 0.47 |
| MACD | -0.07 | 0.08 |
| Stochastic Oscillator | 60.10 | 43.62 |
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.